Cells were passaged at confluence with 0.05% trypsin and maintained in a 37 C incubator with humidified atmosphere of 5% CO 2 and 95% air
Article Title : [Not specified in the provided content] News Publication Date : [Not specified in the provided content] Web References : doi:10.1001/jamahealthforum.2025.4258 Keywords : Peptides, Agonists, Cohort studies, Racial differences, Ethnicity, Medications, Pharmaceuticals, Health care costs, Health insurance Tags: chronic disease management inequalitieseconomic factors in medication adherenceGLP-1 receptor agonists prescription disparitiesglycemic control and weight managementhealthcare equity in pharmaceutical accessmedication adherence in type 2 diabetesnon-Hispanic Black and Hispanic health disparitiesout-of-pocket costs for diabetes medicationspolicy implications for diabetes careprescription fill rates by demographicrace and ethnicity in diabetes treatmentsystemic barriers in healthcare access
Nonetheless, the absence of approval from the U
After market hours Wednesday, the company reported a 69% year-on-year decline in consolidated net profit to Rs 443 crore for the first quarter ended June, hurt by lower sales of cancer drug lenalidomide and a one-time provision linked to the semaglutide API
